Olga Radkevich-Brown

Genetic regulation of the response to Her-2 DNA vaccination in human Her-2 transgenic mice.

Wei-Zen Wei, M. Kershaw, J. Jacob, 2009, Cancer research.

Her-2 DNA versus cell vaccine: immunogenicity and anti-tumor activity

Wei-Zen Wei, Richard F. Jones, J. Jacob, 2009, Cancer Immunology, Immunotherapy.

The “A, B and C” of Her-2 DNA vaccine development

Wei-Zen Wei, J. Jacob, Y. Kong, 2008, Cancer Immunology, Immunotherapy.

Differentiating Deep Tissue Pressure Injury (DTPI) From Other Causes of Purpura in the Sacrococcygeal Area

C. LaFond, Olga Radkevich-Brown, Susan Solmos, 2019, Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society.

Bullous Dermolysis of the Newborn: Four New Cases and Clinical Review

T. Shwayder, Olga Radkevich-Brown, 2013, Pediatric dermatology.

The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity.

M. Greene, yang-xin fu, Shengdian Wang, 2010, Cancer cell.

Cetuximab-mediated tumor regression depends on innate and adaptive immune responses.

yang-xin fu, Xuanming Yang, Eric D. Mortenson, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

Combining human and rat sequences in her-2 DNA vaccines blunts immune tolerance and drives antitumor immunity.

M. Piechocki, A. Amici, Joyce D. Reyes, 2010, Cancer research.

Intratumoral DNA electroporation induces anti-tumor immunity and tumor regression

M. Piechocki, Wei-Zen Wei, S. Pilon-Thomas, 2010, Cancer Immunology, Immunotherapy.

Correction: Combining human and rat sequences in Her-2 DNA vaccines blunts immune tolerance and drives antitumor immunity (Cancer Research (2010) 70, (119-128))

M. Piechocki, A. Amici, Joyce D. Reyes, 2010 .

Cetuximab-mediated tumor regression depends on innate and adaptive immune responses.

yang-xin fu, Xuanming Yang, Eric D. Mortenson, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

Combining human and rat sequences in her-2 DNA vaccines blunts immune tolerance and drives antitumor immunity.

M. Piechocki, A. Amici, Joyce D. Reyes, 2010, Cancer research.